Efficacy of an novel Oral Janus Kinase 1 Inhibitor Abrocitinib on for patients with Atopic Dermatitis: a systematic review and meta-analysis
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI